Castle Biosciences
Castle Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
About Castle Biosciences
Based in the United States, Castle Biosciences is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Castle Biosciences develops and commercializes molecular diagnostic tests using genomic and proteomic technologies to provide risk stratification and clinical decision support for patients with skin cancers and other malignancies such as melanoma, squamous cell carcinoma, uveal melanoma, and Barrett's esophagus.
Explore Castle Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.